Tuesday, Nov. 3, 2026 A Vik Media Group publication
Mongevity Longevity in Motion
Leer en español
Developing story/Hormones

Menopause

11 articles · following since Nov. 3, 2026 · last update Nov. 3, 2026

Every update, newest first

  1. For menopause symptoms after breast cancer, vaginal laser was no better than a sham

    In a double-blind trial published Oct. 1, 2026, in JAMA Network Open, breast cancer survivors on aromatase inhibitors with vaginal dryness and painful sex improved over 12 months, but CO2 laser therapy added no benefit over a sham laser.

  2. Oral estrogen, including menopause pills, was linked to a rare blistering skin disease

    In a Danish nationwide study published Oct. 28, 2026, in JAMA Dermatology, women who used estrogen-containing therapy had higher odds of porphyria cutanea tarda (adjusted odds ratio 2.03). Oral therapy was linked to the disease; non-oral routes were not.

  3. Oral estrogen, including menopause pills, was linked to a rare blistering skin disease

    In a Danish nationwide study published Oct. 28, 2026, in JAMA Dermatology, women who used estrogen-containing therapy had higher odds of porphyria cutanea tarda (adjusted odds ratio 2.03). Oral therapy was linked to the disease; non-oral routes were not.

  4. Menopause may be less a slow slope than a cliff, 300 million lab tests suggest

    A study of 300 million laboratory tests, published in October 2026 in Nature Medicine, found a step-like 'cliff' in women's hormones, bones, liver, kidneys and cholesterol at the final menstrual period, absent in men and softened by menopausal hormone therapy.

  5. Menopause may be less a slow slope than a cliff, 300 million lab tests suggest

    A study of 300 million laboratory tests, published in October 2026 in Nature Medicine, found a step-like 'cliff' in women's hormones, bones, liver, kidneys and cholesterol at the final menstrual period, absent in men and softened by menopausal hormone therapy.

  6. Menopause hormone pills raised clot risk slightly; patches and gels did not

    A Danish nationwide study published Sept. 23, 2026, in The BMJ found that oral menopausal hormone therapy was linked to more venous blood clots (hazard ratio 1.6), while transdermal therapy, through the skin, was not linked to more clots.

  7. Menopause hormone pills raised clot risk slightly; patches and gels did not

    A Danish nationwide study published Sept. 23, 2026, in The BMJ found that oral menopausal hormone therapy was linked to more venous blood clots (hazard ratio 1.6), while transdermal therapy, through the skin, was not linked to more clots.

  8. Menopause caused by surgery or treatment before 45 was linked to higher heart risk

    A meta-analysis of 36 studies, published Oct. 1, 2026, in JAMA Network Open, linked menopause caused by surgery or medical treatment to more heart disease and stroke, with higher mortality only when it happened before age 45.

  9. Menopause caused by surgery or treatment before 45 was linked to higher heart risk

    A meta-analysis of 36 studies, published Oct. 1, 2026, in JAMA Network Open, linked menopause caused by surgery or medical treatment to more heart disease and stroke, with higher mortality only when it happened before age 45.

  10. Diabetes risk was higher after surgical menopause, especially before 45

    A French study of 82,472 women followed for a median 16 years, published Oct. 23, 2026, in Maturitas, linked hysterectomy with removal of both ovaries to a higher risk of type 2 diabetes (hazard ratio 1.23), especially before age 45…

  11. Diabetes risk was higher after surgical menopause, especially before 45

    A French study of 82,472 women followed for a median 16 years, published Oct. 23, 2026, in Maturitas, linked hysterectomy with removal of both ovaries to a higher risk of type 2 diabetes (hazard ratio 1.23), especially before age 45…